Literature DB >> 23392640

Measurement of MHC/peptide interactions by gel filtration or monoclonal antibody capture.

John Sidney1, Scott Southwood, Carrie Moore, Carla Oseroff, Clemencia Pinilla, Howard M Grey, Alessandro Sette.   

Abstract

This unit describes a technique for the direct and quantitative measurement of the capacity of peptide ligands to bind Class I and Class II MHC molecules. The binding of a peptide of interest to MHC is assessed based on its ability to inhibit the binding of a radiolabeled probe peptide to purified MHC molecules. This unit includes protocols for the purification of Class I and Class II MHC molecules by affinity chromatography, and for the radiolabeling of peptides using the chloramine T method. An alternate protocol describes alterations in the basic protocol that are necessary when performing direct binding assays, which are required for (1) selecting appropriate high-affinity, assay-specific, radiolabeled ligands, and (2) determining the amount of MHC necessary to yield assays with the highest sensitivity. After a predetermined incubation period, dependent upon the allele under examination, the bound and unbound radiolabeled species are separated, and their relative amounts are determined. Three methods for separation are described, two utilizing size-exclusion gel-filtration chromatography and a third using monoclonal antibody capture of MHC. Data analysis for each method is also explained.
© 2013 by John Wiley & Sons, Inc.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23392640      PMCID: PMC3626435          DOI: 10.1002/0471142735.im1803s100

Source DB:  PubMed          Journal:  Curr Protoc Immunol        ISSN: 1934-3671


  116 in total

1.  Simultaneous prediction of binding capacity for multiple molecules of the HLA B44 supertype.

Authors:  John Sidney; Scott Southwood; Valerie Pasquetto; Alessandro Sette
Journal:  J Immunol       Date:  2003-12-01       Impact factor: 5.422

Review 2.  Chemistry of peptide interactions with MHC proteins.

Authors:  A Sette; H M Grey
Journal:  Curr Opin Immunol       Date:  1992-02       Impact factor: 7.486

3.  On the interaction of promiscuous antigenic peptides with different DR alleles. Identification of common structural motifs.

Authors:  D O'Sullivan; T Arrhenius; J Sidney; M F Del Guercio; M Albertson; M Wall; C Oseroff; S Southwood; S M Colón; F C Gaeta
Journal:  J Immunol       Date:  1991-10-15       Impact factor: 5.422

4.  Peptide binding to HLA class I molecules: homogenous, high-throughput screening, and affinity assays.

Authors:  Mikkel Harndahl; Sune Justesen; Kasper Lamberth; Gustav Røder; Morten Nielsen; Søren Buus
Journal:  J Biomol Screen       Date:  2009-02-04

5.  Identification of human MHC class I binding peptides using the iTOPIA- epitope discovery system.

Authors:  Markus Wulf; Petra Hoehn; Peter Trinder
Journal:  Methods Mol Biol       Date:  2009

6.  The binding affinity and dissociation rates of peptides for class I major histocompatibility complex molecules.

Authors:  V Cerundolo; T Elliott; J Elvin; J Bastin; H G Rammensee; A Townsend
Journal:  Eur J Immunol       Date:  1991-09       Impact factor: 5.532

7.  Autologous peptides constitutively occupy the antigen binding site on Ia.

Authors:  S Buus; A Sette; S M Colon; H M Grey
Journal:  Science       Date:  1988-11-18       Impact factor: 47.728

8.  Molecular determinants of T cell epitope recognition to the common Timothy grass allergen.

Authors:  Carla Oseroff; John Sidney; Maya F Kotturi; Ravi Kolla; Rafeul Alam; David H Broide; Stephen I Wasserman; Daniela Weiskopf; Denise M McKinney; Jo L Chung; Arnd Petersen; Howard Grey; Bjoern Peters; Alessandro Sette
Journal:  J Immunol       Date:  2010-06-16       Impact factor: 5.422

9.  Peptide binding to the most frequent HLA-A class I alleles measured by quantitative molecular binding assays.

Authors:  A Sette; J Sidney; M F del Guercio; S Southwood; J Ruppert; C Dahlberg; H M Grey; R T Kubo
Journal:  Mol Immunol       Date:  1994-08       Impact factor: 4.407

10.  HLA class I supertypes: a revised and updated classification.

Authors:  John Sidney; Bjoern Peters; Nicole Frahm; Christian Brander; Alessandro Sette
Journal:  BMC Immunol       Date:  2008-01-22       Impact factor: 3.615

View more
  83 in total

1.  Atheroprotective vaccination with MHC-II-restricted ApoB peptides induces peritoneal IL-10-producing CD4 T cells.

Authors:  Takayuki Kimura; Kevin Tse; Sara McArdle; Teresa Gerhardt; Jacqueline Miller; Zbigniew Mikulski; John Sidney; Alessandro Sette; Dennis Wolf; Klaus Ley
Journal:  Am J Physiol Heart Circ Physiol       Date:  2017-01-13       Impact factor: 4.733

2.  Machine learning reveals a non-canonical mode of peptide binding to MHC class II molecules.

Authors:  Massimo Andreatta; Vanessa I Jurtz; Thomas Kaever; Alessandro Sette; Bjoern Peters; Morten Nielsen
Journal:  Immunology       Date:  2017-06-19       Impact factor: 7.397

3.  Peptide-binding motifs of two common equine class I MHC molecules in Thoroughbred horses.

Authors:  Tobias Bergmann; Mikaela Lindvall; Erin Moore; Eugene Moore; John Sidney; Donald Miller; Rebecca L Tallmadge; Paisley T Myers; Stacy A Malaker; Jeffrey Shabanowitz; Nikolaus Osterrieder; Bjoern Peters; Donald F Hunt; Douglas F Antczak; Alessandro Sette
Journal:  Immunogenetics       Date:  2017-03-18       Impact factor: 2.846

Review 4.  Epitope prediction and identification- adaptive T cell responses in humans.

Authors:  John Sidney; Bjoern Peters; Alessandro Sette
Journal:  Semin Immunol       Date:  2020-10-31       Impact factor: 11.130

5.  The common equine class I molecule Eqca-1*00101 (ELA-A3.1) is characterized by narrow peptide binding and T cell epitope repertoires.

Authors:  Tobias Bergmann; Carrie Moore; John Sidney; Donald Miller; Rebecca Tallmadge; Rebecca M Harman; Carla Oseroff; Amanda Wriston; Jeffrey Shabanowitz; Donald F Hunt; Nikolaus Osterrieder; Bjoern Peters; Douglas F Antczak; Alessandro Sette
Journal:  Immunogenetics       Date:  2015-09-23       Impact factor: 2.846

6.  MHC-I peptide binding activity assessed by exchange after cleavage of peptide covalently linked to β2-microglobulin.

Authors:  Mollie M Jurewicz; Richard A Willis; Vasanthi Ramachandiran; John D Altman; Lawrence J Stern
Journal:  Anal Biochem       Date:  2019-06-13       Impact factor: 3.365

Review 7.  Vaccination to modulate atherosclerosis.

Authors:  Takayuki Kimura; Kevin Tse; Alessandro Sette; Klaus Ley
Journal:  Autoimmunity       Date:  2015-02-16       Impact factor: 2.815

8.  A novel method to measure HLA-DM-susceptibility of peptides bound to MHC class II molecules based on peptide binding competition assay and differential IC(50) determination.

Authors:  Liusong Yin; Lawrence J Stern
Journal:  J Immunol Methods       Date:  2014-02-25       Impact factor: 2.303

9.  A Case of Human Lassa Virus Infection With Robust Acute T-Cell Activation and Long-Term Virus-Specific T-Cell Responses.

Authors:  Anita K McElroy; Rama S Akondy; Jessica R Harmon; Ali H Ellebedy; Deborah Cannon; John D Klena; John Sidney; Alessandro Sette; Aneesh K Mehta; Colleen S Kraft; Marshall G Lyon; Jay B Varkey; Bruce S Ribner; Stuart T Nichol; Christina F Spiropoulou
Journal:  J Infect Dis       Date:  2017-06-15       Impact factor: 5.226

10.  HLA class I alleles are associated with peptide-binding repertoires of different size, affinity, and immunogenicity.

Authors:  Sinu Paul; Daniela Weiskopf; Michael A Angelo; John Sidney; Bjoern Peters; Alessandro Sette
Journal:  J Immunol       Date:  2013-11-04       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.